IL264576A - Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth - Google Patents

Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth

Info

Publication number
IL264576A
IL264576A IL264576A IL26457619A IL264576A IL 264576 A IL264576 A IL 264576A IL 264576 A IL264576 A IL 264576A IL 26457619 A IL26457619 A IL 26457619A IL 264576 A IL264576 A IL 264576A
Authority
IL
Israel
Prior art keywords
preterm
biomarkers
premature rupture
predicting
spontaneous labor
Prior art date
Application number
IL264576A
Other languages
English (en)
Hebrew (he)
Inventor
Durlin Edward Hickok
John Jay Boniface
Julja Burchard
Greg Charles Critchfield
Tracey Cristine Fleischer
Chien Hsu
Original Assignee
Sera Prognostics Inc
Durlin Edward Hickok
John Jay Boniface
Julja Burchard
Greg Charles Critchfield
Tracey Cristine Fleischer
Chien Hsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sera Prognostics Inc, Durlin Edward Hickok, John Jay Boniface, Julja Burchard, Greg Charles Critchfield, Tracey Cristine Fleischer, Chien Hsu filed Critical Sera Prognostics Inc
Publication of IL264576A publication Critical patent/IL264576A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL264576A 2016-08-05 2019-01-31 Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth IL264576A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662371666P 2016-08-05 2016-08-05
US201762449862P 2017-01-24 2017-01-24
PCT/US2017/045576 WO2018027171A1 (en) 2016-08-05 2017-08-04 Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor

Publications (1)

Publication Number Publication Date
IL264576A true IL264576A (en) 2019-02-28

Family

ID=61073085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264576A IL264576A (en) 2016-08-05 2019-01-31 Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth

Country Status (10)

Country Link
US (3) US20180172698A1 (enExample)
EP (1) EP3494233A4 (enExample)
JP (2) JP2019532261A (enExample)
KR (1) KR20190046825A (enExample)
CN (1) CN110191963A (enExample)
AU (1) AU2017307584A1 (enExample)
CA (1) CA3032754A1 (enExample)
IL (1) IL264576A (enExample)
RU (1) RU2019105691A (enExample)
WO (1) WO2018027171A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL256399B (en) 2015-06-19 2022-09-01 Sera Prognostics Inc Biomarker pairs for predicting preterm birth
WO2019036032A1 (en) * 2017-08-18 2019-02-21 Sera Prognostics, Inc PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH
AU2018357888A1 (en) * 2017-10-30 2020-05-28 Carmentix Pte. Ltd. Biomarkers of preterm birth
CA3186291A1 (en) * 2020-06-10 2021-12-16 Board Of Regents, The University Of Texas System Method for determining risk of pre-term birth
US20240013925A1 (en) * 2020-11-05 2024-01-11 Board Of Regents, The University Of Texas System Individual optimal mode of delivery
CA3220282A1 (en) * 2021-05-21 2022-11-24 Sera Prognostics, Inc. Biomarker pairs and triplets for predicting preterm birth
RU2763707C1 (ru) * 2021-06-01 2021-12-30 Наталья Борисовна Кузнецова Способ прогнозирования преждевременного разрыва плодных оболочек в сроке от 22 до 28 недель беременности
WO2023023475A1 (en) * 2021-08-17 2023-02-23 Birth Model, Inc. Predicting time to vaginal delivery
CN118056016A (zh) * 2021-12-08 2024-05-17 深圳华大基因股份有限公司 基因标志物在预测孕妇早产风险中的应用
WO2024156709A1 (en) * 2023-01-24 2024-08-02 Université Clermont Auvergne Evaluation of serum cx3cl1 for the prediction of preterm premature rupture of membranes
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
RU2586412C2 (ru) * 2012-06-09 2016-06-10 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ оценки риска возникновения патологии беременности
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US20160003837A1 (en) * 2013-01-08 2016-01-07 Duke University Biomarkers for the prediction of preterm birth
AU2014227891A1 (en) * 2013-03-15 2015-10-08 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
US20140287948A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
CA3210007A1 (en) * 2013-03-15 2014-09-18 Sera Prognostics, Inc Biomarkers and methods for predicting preeclampsia
IL256399B (en) * 2015-06-19 2022-09-01 Sera Prognostics Inc Biomarker pairs for predicting preterm birth

Also Published As

Publication number Publication date
EP3494233A1 (en) 2019-06-12
US20210190792A1 (en) 2021-06-24
CN110191963A (zh) 2019-08-30
CA3032754A1 (en) 2018-02-08
EP3494233A4 (en) 2020-03-18
KR20190046825A (ko) 2019-05-07
JP2022140511A (ja) 2022-09-26
RU2019105691A (ru) 2020-09-08
US20250085293A1 (en) 2025-03-13
JP2019532261A (ja) 2019-11-07
US20180172698A1 (en) 2018-06-21
WO2018027171A1 (en) 2018-02-08
AU2017307584A1 (en) 2019-03-21

Similar Documents

Publication Publication Date Title
IL264576A (en) Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth
IL286853B (en) Methods for diagnosing sepsis
IL256399A (en) Pairs of biomarkers for predicting premature birth
ZA201607414B (en) Method for dry reforming of at least one alkane
EP3368474A4 (en) ELECTROCHEMICAL GAS SEPARATION METHOD
GB201402293D0 (en) Biomarker signatures for the prediction of onset of sepsis
PL3256853T3 (pl) Przewidywanie epitopów komórek T przydatnych do szczepienia
ZA201704499B (en) Gammadelta t cell expansion procedure
DK3785799T3 (da) Fremstillingsfremgangsmåder til vanddispergerbare assays
IL283015A (en) Identifying male fertility status by determining sperm quality
GB201403432D0 (en) Improved method for synthesis of composite membranes
IL274325A (en) Biomarkers for preterm birth
EP3494232A4 (en) BIOMARKERS FOR PREDICTING PREMATURE DELIVERY IN A GRAVID FEMALE EXPOSED TO PROGESTOGENS
NO20190593A1 (en) Prediction of methane hydrate production parameters
EP3273980A4 (en) Use of ccl2 to inhibit abnormal uterine bleeding
EP3105353A4 (en) P13k-mtorc1-s6k1 signaling pathway biomarkers predictive of anti-cancer responses
GB2557797B (en) Chemical means to predict end of job in reverse-circulation cementing
GB201704915D0 (en) Electrochemical corrosion of catalyst material for PCD elements
ME03552B (me) Novi kristalni oblici mononatrijumove soli foramsulfurona
FR3040066B1 (fr) Installation sous-marine de separation gaz/liquide
BR112016026261A2 (pt) método para secar um gás a frio
GB2517004B (en) High-throughput mass-spectrometric characterization of samples
IL252944B (en) Granticin B polymorph
SG11201702174UA (en) Setting method for conductive object of electrochemical test strip
GB201511542D0 (en) Use of cell free nucleosomes as biomarkers